Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows used in operating activities
Net loss	$ (21,320,178)	$ (16,010,287)
Adjustments to reconcile net loss to net cash used in operations:
Stock-based compensation	8,348,230	2,785,470
Changes in working capital balances:
Incentive and tax receivables	2,667,844	(2,478,750)
Prepaid expenses and other current assets	(109,056)	57,030
Accounts payable	(2,107,893)	(331,002)
Accrued liabilities	(619,386)	302,205
Deferred grant income		487,111
Net cash used in operating activities	(13,140,439)	(15,188,223)
Cash flows provided by financing activities
Issuance of common shares	14,399,768	61,934,439
Share issue costs	(521,441)	(1,134,697)
Proceeds from exercise of stock options	496,923	998,802
Net cash provided by financing activities	14,375,250	61,798,544
Increase in cash and cash equivalents during the period	1,234,811	46,610,321
Cash and cash equivalents, beginning of period	152,107,745	29,249,018
Cash and cash equivalents, end of period	153,342,556	75,859,339
Supplemental Cash Flow Information
Cash paid for state and local minimum income taxes	$ 141,374	$ 59,281